Shares of WELL jumped 4.3% Thursday, closing at $208.24, as the health-care REIT heads into its April 27 earnings release. Short sellers have added cautiously over the past month, but positioning remains light ahead of the print.
Short interest sits at 2.50% of free float, totaling 17.15 million shares as of April 22. That marks a 10.5% increase over the past month. Over the week, short sellers added marginally, with shares short rising 0.15%. Days to cover stands at 4.99, reflecting modest selling pressure relative to average volume. Cost to borrow ticked up 4.9% over the month to 0.54%, still near the lower end of the borrowing spectrum.
Put/call ratio sits at 0.84, just below its 20-day mean of 0.86. The Z-score of -0.19 signals neutral sentiment. Options traders appear unexcited heading into earnings. The PCR has traded as high as 8.06 and as low as 0.26 over the past year, placing current levels in balanced territory.
Analyst data is unavailable in the snapshot. No recent upgrades or downgrades are recorded ahead of the print.
Welltower most recently reported on February 10, 2026. Prior earnings events clustered in mid-February, with announcements typically occurring after market close. The stock has climbed 6.8% over the past month, outpacing the 2.9% pullback seen over the week.
No active ORTEX Alpha signals are flagged for Welltower. The ORTEX short score of 37.8 places the stock in the mid-range of short-related metrics, unchanged materially over the past two weeks.
See the live data behind this article on ORTEX.
Open WELL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.